赫拉
纳米医学
体外
荧光
癌细胞
PEG比率
细胞凋亡
纳米技术
化学
癌症研究
细胞
生物物理学
材料科学
癌症
纳米颗粒
医学
生物化学
生物
物理
内科学
经济
量子力学
财务
作者
Ranxi Liang,Zhonghui Liao,Feize Li,Huan Ma,Weihao Liu,Xijian Chen,Tu Lan,Yuanyou Yang,Jiali Liao,Jijun Yang,Ning Liu
标识
DOI:10.1002/chem.202104589
摘要
In past decades, nanoscale metal-organic frameworks (NMOFs) have drawn more and more attention in multimodal imaging and targeting therapy of various malignant cancers. Here, we proposed to dope 111 In into fluorescent In-based NMOFs (In-MIL-68-NH2 ), with an attempt to prepare a new nanomedicine with great anticancer potential. As a proof of concept, the obtained NMOF (In-MIL-68/PEG-FA) with targeting motifs is able to act as a fluorescent probe to achieve Hela cell imaging. Moreover, the Auger electron emitter 111 In built in corresponding radioactive NMOF (111 In-MIL-68/PEG-FA) can bring clear damage to cancer cells, leading to a high cell killing rate of 59.3 % within 48 h. In addition, the cell cycle presented a significant dose-dependent G2/M inhibiting mode, which indicates that 111 In-MIL-68/PEG-FA has the ability to facilitate the cancer cells to enter apoptotic program. This work demonstrated the potential of 111 In-labelled NMOFs in specific killings of cancer cells, providing a new approach to develop nanomedicines with theranostic function.
科研通智能强力驱动
Strongly Powered by AbleSci AI